Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Craig-Hallum Downgrades Quotient Technology to Hold

Craig-Hallum Downgrades Quotient Technology to Hold

Craig-Hallum analyst Chad Bennett downgrades Quotient Technology (NYSE:QUOT) from Buy to Hold.

byBenzinga Newsdesk

August 10, 2022

1 minute read

Craig-Hallum analyst Chad Bennett downgrades Quotient Technology (NYSE:QUOT) from Buy to Hold.

Morgan Stanley Maintains Overweight on Inari Medical, Lowers Price Target to $83

By Benzinga Newsdesk

January 6, 10:40 AM

Morgan Stanley analyst Cecilia Furlong maintains Inari Medical (NASDAQ:NARI) with a Overweight and lowers the price target from $95 to $83.

NARI

Lowe’s FY23 Outlook: Revenue $88B – $90B Vs. $90.66B Estimate, EPS $13.60 – $14.00 Vs. $13.84 Estimate. Comparable Sales Flat – (2)% YoY

By Benzinga Newsdesk

March 1, 7:05 AM

Full Year 2023 Outlook -- a 52-week Year (comparisons to full year 2022 -- a 53-week year) Total sales of approximately $88 – $90 billion Comparable sales expected to be flat to

LOW

Analyst Ratings

Where R1 RCM Stands With Analysts

By Benzinga Insights

December 5, 1:03 PM

Within the last quarter, R1 RCM (NASDAQ:RCM) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

RCM

AMD Faces New Challenge as China Advances with RISC-V Chip Technology

By Anusuya Lahiri

February 5, 9:32 AM

AMD & Intel dominate x86 chip market, but China's push for RISC-V architecture challenges their dominance and reshapes chip industry.

AMD

Craig-Hallum Downgrades Quotient Technology to Hold

Related Posts

Morgan Stanley Maintains Overweight on Inari Medical, Lowers Price Target to $83

Lowe’s FY23 Outlook: Revenue $88B – $90B Vs. $90.66B Estimate, EPS $13.60 – $14.00 Vs. $13.84 Estimate. Comparable Sales Flat – (2)% YoY

Where R1 RCM Stands With Analysts

AMD Faces New Challenge as China Advances with RISC-V Chip Technology